ANNA Home Page
ANNA CE Link
HDCN Home Page
HDCN Registration Link

If you dont have an Acrobat Reader installed on your computer, you may download it for free from the link below:


IV Iron Therapy and Anemia Management In Patients on Hemodialysis: Benefits Of a Revised CQI Strategy
(Vol 35/No. 4. On-line test expires: 08/31/2010)
To receive continuing education credit, you must read the information in this article and take an on-line post test and fill out an on-line program evaluation form. The certificate will then be generated for you as a .pdf file which you can print out locally on your computer.

CE Certification by ANNA requires a handling charge that must be paid by credit card. Pricing information is available by clicking on the "Post-Test Evaluation" link below.
  DOWNLOAD TEST ARTICLE
Please download and print the PDF file below:
  AUTHOR
Deborah Bowe, RN, CNN
 Deborah Bowe, RN, CNN, is a Clinical Administrator, Kidney Institute of Wisconsin, LLC, Glendale, WI, and a Member of ANNA’s Wisconsin Chapter #304.
  OUTLINE

Intravenous iron therapy is widely used in the management of anemia in patients on hemodialysis, and anemia management protocols provide a standardized approach to IV iron therapy. The author’s hemodialysis center implemented an initial anemia management protocol in 2004 based on the principles of a continuous quality improvement (CQI) program, detailed by Bowe and Ammel in the Nephrology Nursing Journal in 2005. Successive revision using the CQI process has resulted in additional benefits regarding patient outcomes, which are reported here. This article illustrates the value of a CQI program for maintaining and improving clinical outcomes in patients who have anemia and are undergoing hemodialysis.
  GET YOUR CE CERTIFICATE
Take on-line Quiz:
  CE RELATED INFORMATION
This offering for 1.4 contact hours is being provided by the American Nephrology Nurses’ Association (ANNA), which is accredited as a provider and approver of continuing education in nursing by the American Nurses’ Credentialing Center-Commission on Accreditation (ANCCCOA). This educational activity is approved by most states and specialty organizations that recognize the ANCC-COA accreditation process. ANNA is an approved provider of continuing education in nursing by the California Board of Registered Nursing, BRN Provider No. 00910; and the Kansas State Board of Nursing, Provider No. LT0148-0738. This offering is accepted for RN and LPN relicensure in Kansas.

  EDUCATIONAL OBJECTIVES

Goal:
To illustrate how the successive use of a continuous quality improvement program for maintaining and improving an intravenous iron and anemia management protocol can improve patient outcomes.

 Objectives:
1. Describe the revision of an anemia management protocol in the context of an established CQI process.
2. Explain how evidence-based literature on erythropoietin-stimulating agents and IV iron therapy should be used to drive CQI revision.
3. Evaluate the effects on patient outcomes of a revised anemia management protocol using the CQI process.

AUTHOR DISCLOSURE STATEMENT

Deborah Bowe The author reported that she is on the Watson Pharmaceuticals Speakers’ Bureau.


 ANNA and HDCN CE POLICY STATEMENTS

The CE policy and disclosure statements of the American Nephrology Nurses' Association are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.